Downregulation of hsa-miR-99a, as shown in our study, leads to abnormal expression of the FGFR3 gene, resulting in the activation of PI3K-AKT and RAS/RAF/MEK/MAPK signaling pathways involved in tumor progression [77,78,79]. This evidence concerns the gene FGFR3 and neoplasm.